Expression of MUC1 in eosinophilic metaplasia of the prostate.


Journal

The Prostate
ISSN: 1097-0045
Titre abrégé: Prostate
Pays: United States
ID NLM: 8101368

Informations de publication

Date de publication:
05 2019
Historique:
received: 07 11 2018
accepted: 27 12 2018
pubmed: 18 1 2019
medline: 4 12 2019
entrez: 18 1 2019
Statut: ppublish

Résumé

Eosinophilic metaplasia (EM) in the prostate is characterized by the presence of eosinophilic cytoplasmic granules in benign prostatic epithelium. These granules show exocrine-type morphology and positive expression for prostate specific antigen (PSA) and some lysosomal markers. The nature and the full immunohistochemical profile of the granules of EM have not been studied in detail yet. The aim of the current study is to investigate the expression of epithelial mucins (MUCs) in prostatic epithelium with EM. Twenty specimens from transurethral resection of the prostate (TURP) were reviewed for the presence of EM and were stained with Periodic acid-Schiff's procedure with diastase digestion (PAS.D) and immunostained with PSA and MUCs: MUC1, MUC2, MUC5AC, and MUC6. The EM-foci of all prostate glands are PAS.D, PSA positive and show constant immunoreactivity for MUC1. The expression of MUC1 is with membranous and cytoplasmic localization: predominantly apical with membranous accentuation in the cases of EM with large eosinophilic granules, and perinuclear in EM with small eosinophilic granules. There is no expression of other MUCs (MUC2, MUC5AC, and MUC6) in prostatic EM. We report for the first time that eosinophilic cytoplasmic granules in prostatic EM are MUC1 positive and can vary in size. Based on our immunohistochemical study we suggest that EM of the prostate is not a form of mucinous metaplasia. The present results enrich the available information about the immunophenotype of EM. We assume that MUC1 might serve as a reliable and constant, although nonspecific, immunohistochemical marker of benign EM-phenotype.

Sections du résumé

BACKGROUND
Eosinophilic metaplasia (EM) in the prostate is characterized by the presence of eosinophilic cytoplasmic granules in benign prostatic epithelium. These granules show exocrine-type morphology and positive expression for prostate specific antigen (PSA) and some lysosomal markers. The nature and the full immunohistochemical profile of the granules of EM have not been studied in detail yet.
AIM
The aim of the current study is to investigate the expression of epithelial mucins (MUCs) in prostatic epithelium with EM.
METHODS
Twenty specimens from transurethral resection of the prostate (TURP) were reviewed for the presence of EM and were stained with Periodic acid-Schiff's procedure with diastase digestion (PAS.D) and immunostained with PSA and MUCs: MUC1, MUC2, MUC5AC, and MUC6.
RESULTS
The EM-foci of all prostate glands are PAS.D, PSA positive and show constant immunoreactivity for MUC1. The expression of MUC1 is with membranous and cytoplasmic localization: predominantly apical with membranous accentuation in the cases of EM with large eosinophilic granules, and perinuclear in EM with small eosinophilic granules. There is no expression of other MUCs (MUC2, MUC5AC, and MUC6) in prostatic EM.
CONCLUSION
We report for the first time that eosinophilic cytoplasmic granules in prostatic EM are MUC1 positive and can vary in size. Based on our immunohistochemical study we suggest that EM of the prostate is not a form of mucinous metaplasia. The present results enrich the available information about the immunophenotype of EM. We assume that MUC1 might serve as a reliable and constant, although nonspecific, immunohistochemical marker of benign EM-phenotype.

Identifiants

pubmed: 30652335
doi: 10.1002/pros.23769
doi:

Substances chimiques

Biomarkers 0
MUC1 protein, human 0
Mucin-1 0
Mucins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

622-627

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Maria Koleva (M)

Department of General and Clinical Pathology, Medical University of Plovdiv, Plovdiv, Bulgaria.

Dorian Dikov (D)

Department of General and Clinical Pathology, Medical University of Plovdiv, Plovdiv, Bulgaria.
Service d'Anatomie et Cytologie Pathologiques, Grand Hôpital de l'Est Francilien, Jossigny, France.

Veselin Belovejdov (V)

Department of General and Clinical Pathology, Medical University of Plovdiv, Plovdiv, Bulgaria.

Victoria Sarafian (V)

Department of Medical Biology, Medical University of Plovdiv, Plovdiv, Bulgaria.
Technological Center for Emergency Medicine, Plovdiv, Bulgaria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH